This free-to-attend event will focus on the Challenges & Development of New and Existing Therapeutic Research in neuroscience and neurological disorders. As we continue our focus of developing networking opportunities for unmet scientific or technical challenges, we ask the challenging questions, what are the next developments in research to enable disease understanding, what potential disease model applications can be defined and where are the new therapeutic agents which will provide the health industry and the patients with much needed tools for those diseases ? If this is your research area or if you are interested in neuroscience, register now!
Speakers:
Emma Murphy (Alzheimer’s Research UK) “USP8 as a Therapeutic Target in Neurodegeneration”
Matthew Beard (Ipsen) “Building new biotherapeutic medicines from botulinum neurotoxins”
Daniel Ebner (Target Discovery Institute, Oxford) “Challenges of genome-wide CRISPR/Cas9 screening in co-culture of iPSC-derived neurons and microglia”
Our networking events, follow the model of short, informal presentations by guest speakers from academia and industry which encourage and foster collaboration and opportunities between local research groups. The presentations are always followed by a food and drinks reception to facilitate further networking.
We believe that through enhanced collaboration between scientists from academia, pharma / biotech and the technology industry, we can offer the opportunity to create a truly unique and open forum, engaging researchers in a beneficial manner and within a local geographical environment.
Our event sponsors in Oxford are Miltenyi and we are generously hosted and sponsored by Ipsen Bioinnovation in Milton Park, Abingdon, one of the UKs major science parks and home to many key Biotech, Pharma and CRO players in the drug discovery arena.
Venue:
Ipsen Bioinnovation
Location: Milton Park Abingdon Oxford
Country: United Kingdom
Organiser Contact Details:
ELRIGT:
07484 113971info@elrig.org
